MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.00
-0.36 (-3.17%)
Aug 13, 2026, 4:00 PM EDT - Market closed
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $54.8 million as of August 14, 2026. Its market cap has decreased by -3.17% in one year.
Market Cap
54.80M
Enterprise Value
45.99M
1-Year Change
-3.17%
Ranking
Category
Stock Price
$11.00
ChartMarket Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $54.80M, a decrease of -85.82%. That is a compound annual growth rate of -33.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 54.80M | 4.70% |
| Dec 31, 2025 | 52.34M | 89.51% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Boundless Bio | 63.24M |
| MindWalk Holdings | 61.55M |
| Alps Group | 59.57M |
| INmune Bio | 56.62M |
| Immutep | 54.22M |
| Xilio Therapeutics | 54.14M |
| aTyr Pharma | 53.00M |
| eXoZymes | 52.48M |